Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Κατάταξη σε μετοχές #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Τιμή μετοχής
$88.89
Κεφαλαιοποίηση
$114.13B
Αλλαγή (1 ημέρα)
-0.93%
Αλλαγή (1 έτος)
-2.08%
Χώρα
IE
Εμπόριο Medtronic plc (2M6)

Κατηγορία

Κέρδη για την Medtronic plc (2M6)
Κέρδη τον Jan 2026 TTM: $5.56B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Medtronic plc, τα τρέχοντα κέρδη της εταιρείας είναι $5.56B. Το 2024, η εταιρεία παρουσίασε κέρδη $4.84B, μείωση σε σύγκριση με των κερδών του 2023 που ήταν $5.36B. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Medtronic plc από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
Έτος Κέρδη Αλλαγή
2026 (TTM) $5.56B -1.13%
2025 $5.63B 16.35%
2024 $4.84B -9.82%
2023 $5.36B -2.77%
2022 $5.52B 41.64%
2021 $3.90B -3.95%
2020 $4.06B -21.97%
2019 $5.20B -8.42%
2018 $5.68B 23.32%
2017 $4.60B 6.13%
2016 $4.34B 24.38%
2015 $3.49B -5.91%
2014 $3.71B -12.84%
2013 $4.25B 2.56%
2012 $4.15B 11.33%
2011 $3.72B -6.20%
2010 $3.97B 53.01%
2009 $2.59B -10.09%
2008 $2.89B -17.92%
2007 $3.52B 11.19%
2006 $3.16B 24.29%
2005 $2.54B -9.06%
2004 $2.80B 19.46%
2003 $2.34B 53.61%
2002 $1.52B -1.63%
2001 $1.55B -4.89%
2000 $1.63B 0.00%
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
Εταιρεία Κέρδη Διαφορά Κερδών Χώρα
$8.47B 52.15%
US
$4.51B -18.88%
US
$5.56B -0.02%
IE
$3.39B -39.17%
US
$3.13B -43.72%
DE